These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30293110)

  • 61. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
    Kim W; Shim YK; Choi SA; Kim SY; Kim H; Lim BC; Hwang H; Choi J; Kim KJ; Chae JH
    Neuromuscul Disord; 2019 Sep; 29(9):684-692. PubMed ID: 31473049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement.
    Kokubun N; Sada T; Yuki N; Okabe M; Hirata K
    Eur Neurol; 2013; 70(1-2):65-9. PubMed ID: 23796651
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
    Grimm A; Vittore D; Schubert V; Rasenack M; Décard BF; Heiling B; Hammer N; Axer H
    J Neurol; 2016 Jun; 263(6):1074-82. PubMed ID: 27017343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of chronic inflammatory demyelinating polyneuropathy.
    Comi G; Roveri L
    Ital J Neurol Sci; 1998 Oct; 19(5):261-9. PubMed ID: 10933445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Resistance training and aerobic training improve muscle strength and aerobic capacity in chronic inflammatory demyelinating polyneuropathy.
    Markvardsen LH; Overgaard K; Heje K; Sindrup SH; Christiansen I; Vissing J; Andersen H
    Muscle Nerve; 2018 Jan; 57(1):70-76. PubMed ID: 28345260
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.
    Eftimov F; Vermeulen M; van Doorn PA; Brusse E; van Schaik IN;
    Neurology; 2012 Apr; 78(14):1079-84. PubMed ID: 22442436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
    Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Strömberg U; Wahlin A; Isaksson C; Johansson JE; Hägglund H
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):618-24. PubMed ID: 24262917
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Challenges in pediatric chronic inflammatory demyelinating polyneuropathy.
    Haliloğlu G; Yüksel D; Temoçin CM; Topaloğlu H
    Neuromuscul Disord; 2016 Dec; 26(12):817-824. PubMed ID: 27793469
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    Muscle Nerve; 2015 Jun; 51(6):846-52. PubMed ID: 25297575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Muscle Strength and Aerobic Capacity in Patients with CIDP One Year after Participation in an Exercise Trial.
    Markvardsen LK; Carstens AR; Knak KL; Overgaard K; Vissing J; Andersen H
    J Neuromuscul Dis; 2019; 6(1):93-97. PubMed ID: 30507584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.